Biofilm and Quorum Sensing inhibitors: the road so far.

Simone CarradoriNoemi Di GiacomoMartina LobefaloGrazia LuisiCristina CampestreFrancesca Sisto

Published in: Expert opinion on therapeutic patents (2020)

New pharmacological targets have been explored in the past years, allowing a broader therapeutic arsenal against biofilm-related pathologies. The Quorum Sensing system was targeted as well in order to avoid the development of intrinsically antibiotic-resistant bacteria and to enhance a proper host defense.

Keyphrases

pseudomonas aeruginosa
staphylococcus aureus
candida albicans
biofilm formation
cystic fibrosis
cancer therapy
escherichia coli
drug delivery